Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Sep-Oct;19(5):385-90.
doi: 10.1111/j.1521-0391.2010.00061.x.

Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning

Suzette Glasner-Edwards  1 , Larissa J Mooney, Patricia Marinelli-Casey, Maureen Hillhouse, Alfonso Ang, Richard Rawson; Methamphetamine Treatment Project Corporate Authors
Collaborators, Affiliations
Randomized Controlled Trial

Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning

Suzette Glasner-Edwards et al. Am J Addict. 2010 Sep-Oct.

Abstract

Although anxiety is one of the most prominent psychiatric complaints of methamphetamine (MA) users, little is known about the association between anxiety disorders and treatment outcomes in this population. Using data from 526 adults in the largest psychosocial clinical trial of MA users conducted to date, this study examined psychiatric, substance use, and functional outcomes of MA users with concomitant anxiety disorders 3 years after treatment. Anxiety disorders were associated with poorer alcohol and drug use outcomes, increased health service utilization, and higher levels of psychiatric symptomatology, including suicidality. Addressing anxiety symptoms and syndromes in MA users may be helpful as a means of optimizing treatment outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean Addiction Severity Index (ASI) scale scores as a function of time among MA dependent adults with anxiety disorders at 3-year follow-up (N=138).
Figure 2
Figure 2
Mean Addiction Severity Index (ASI) scale scores as a function of time among MA dependent adults without anxiety disorders at 3-year follow-up (N=388).
See this image and copyright information in PMC

References

    1. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13(2):181–190. - PubMed
    1. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review. 2008;27:253–262. - PubMed
    1. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104:1085–1099. - PubMed
    1. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320–1329. - PubMed
    1. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996;91(1):81–87. - PubMed

Publication types